We provide CNS Biomarker Testing Services.  Please contact us at info@nvector.com for further information and pricing.


nVector enables and accelerates breakthrough treatments for previously untreatable diseases of the central nervous system.

Leverage nVector’s advanced Adeno-Associated Virus platform to quick-launch your gene therapy strategy or accelerate existing initiatives. We enhance testing and trials with superior diagnostic biomarkers.

GreenGlia Technology™

With our proprietary GreenGlia Technology, you can target specific glia and neuron cells never before accessible. This enables revolutionary treatments for Alzheimer’s, Parkinson’s, Traumatic Brain Injury, ALS and any other central nervous system (CNS) disease.

The nVector Platform – Next generation impact for CNS solutions

Gene therapy for CNS conditions promises great potential cures. But so far development has been slowed by lack of ability to target and access the right cells, and limited gene expression. Now, the nVector platform can help overcome those barriers.

Capsid Design Library

Identity and access the right viral capsid customized to your unique needs.

Therapeutic Pipeline

Developing treatments addressing ALS, Huntington’s and Parkinson’s and beyond.

Clinical Assays

Offering the first biologic diagnostic test for ALS.

Biomarker Development

Customized CNS biomarker testing and development.